Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
about
Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase.The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms.Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease.
P2860
Dipeptidyl peptidase IV and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@ast
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@en
type
label
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@ast
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@en
prefLabel
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@ast
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@en
P2093
P2860
P50
P356
P1433
P1476
Dipeptidyl peptidase IV and in ...... k in Communities (ARIC) study.
@en
P2093
Atherosclerosis Risk in Communities Investigators
Bruce B Duncan
David Couper
Maria Inês Schmidt
Vivian C Luft
P2860
P304
P356
10.2337/DC09-1996
P407
P577
2010-02-25T00:00:00Z